DJIA 17,079.57 -42.44 -0.25%
NASDAQ 4,557.70 -11.93 -0.26%
S&P 500 1,996.74 -3.38 -0.17%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

60.00 -0.28 (-0.46%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $60.00 -0.46%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $59.89
Previous Close $60.28
Daily Range $59.84 - $60.23
52-Week Range $44.62 - $60.58
Market Cap $173.1B
P/E Ratio 31.73
Dividend (Yield) $1.76 (2.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 5,240,981
Average Daily Volume 7,967,587
Current FY EPS $3.50





Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

Dow Analyst Moves: MRK

I Am Sure This Pharma-Company Suits Your Portfolio

Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

3 Stocks Reiterated As A Buy: PCLN, AAPL, MRK

3 Reasons Merck & Co., Inc.'s Stock Could Fall

Merck's hepatitis C and oncology drug hopefuls have been pushing its stock higher, but these three catalysts could halt its growth prospects dead in their tracks.

Short Interest Swings in High-Yield Dividend Stocks

Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

Will This Coverage Initiation Affect Merck (MRK) Stock Today?

UPDATE: Deutsche Bank Initiates Coverage On Merck

See More MRK News...

MRK's Top Competitors

MRK $60.00 (-0.46%)
Current stock: MRK
JNJ $102.95 (-0.26%)
Current stock: JNJ
NVS $89.73 (-0.30%)
Current stock: NVS
RHHBY $36.56 (-0.19%)
Current stock: RHHBY